Dapsone
Product Images NDC 10135-655

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 10135-655). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dapsone Is Issued On Prescription In Tablets Of 25 And 100 mg For Oral Use. (Dapsone 01)

FDA Label Image

Principal Display Panelndc 10135-0654-30dapsonetablets, Usp25 mg30 Tabletsrx Only (Dapsone 02)

Principal Display Panelndc 10135-0654-30dapsonetablets, Usp25 mg30 Tabletsrx Only (Dapsone 02)
NDC 10135-0654-30 is a USP Dapsone tablet that contains 25 milligrams of the drug. The proper dosage should be read in the accompanying literature. Additionally, the tablets should be stored in a tight light-resistant container at a temperature between 20 to 25 degrees Celsius. The tablets might also be stored at a controlled room temperature between 15 to 30 degrees Celsius. The drug should be kept out of reach of children. Marlex Pharmaceuticals produced and distributed this drug, as denoted by the text.*
FDA Label Image

Principal Display Panelndc 10135-0654-01dapsonetablets, Usp25 mg100 Tabletsrx Only (Dapsone 03)

Principal Display Panelndc 10135-0654-01dapsonetablets, Usp25 mg100 Tabletsrx Only (Dapsone 03)
NDC 10135-0654-01 is a drug manufactured and distributed by Marlex Pharmaceuticals, Inc. It contains Dapsone, USP in tablet form. The usual dosage information is available in the accompanying literature. The drug should be stored between 20° to 25°C (68° to 77°F), with some excursions permitted between 15° to 30°C (59° to 8°F), as per the USP Controlled Room Temperature guidelines. The drug should be kept out of the reach of children and dispensed in a tight, light-resistant container. The text also denotes that the drug requires a prescription.*
FDA Label Image

Principal Display Panelndc 10135-0655-30dapsonetablets, Usp100 mg30 Tabletsrx Only (Dapsone 04)

Principal Display Panelndc 10135-0655-30dapsonetablets, Usp100 mg30 Tabletsrx Only (Dapsone 04)
NDC 10135-0655-30 is a medication that comes in a tablet form containing 100mg of Dapsone USP. The usual dosage and instructions for use can be found in the accompanying literature. Store the tablets at 20° to 25°C (68° to 77°F). It is recommended to keep the medication in a tight light resistant container and out of the reach of children. This medication is manufactured and distributed by Marlex Pharmaceuticals, Inc.*
FDA Label Image

Principal Display Panelndc 10135-0655-01dapsonetablets, Usp100 mg100 Tabletsrx Only (Dapsone 05)

Principal Display Panelndc 10135-0655-01dapsonetablets, Usp100 mg100 Tabletsrx Only (Dapsone 05)
This is a medication label for Dapsone tablets with the NDC code 10135-0655-01. Each tablet contains 100mg of Dapsone, and the recommended dosage and storage instructions are included. The medication should be stored in a tight, light-resistant container at a controlled room temperature between 20° to 30°C (68° to 86°F), with excursions permitted. Additionally, the label includes a warning to keep the medication and all drugs out of the reach of children. The tablets are manufactured for/distributed by Marlex Pharmaceuticals and the label is dated May 2018.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.